Atıf Formatları
Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Ş. BEYDEMİR Et Al. , "Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies," DRUG AND CHEMICAL TOXICOLOGY , vol.44, no.5, pp.508-517, 2021

BEYDEMİR, Ş. Et Al. 2021. Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies. DRUG AND CHEMICAL TOXICOLOGY , vol.44, no.5 , 508-517.

BEYDEMİR, Ş., TÜRKEŞ, C., & Yalcin, A., (2021). Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies. DRUG AND CHEMICAL TOXICOLOGY , vol.44, no.5, 508-517.

BEYDEMİR, ŞÜKRÜ, CÜNEYT TÜRKEŞ, And Ahmet Yalcin. "Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies," DRUG AND CHEMICAL TOXICOLOGY , vol.44, no.5, 508-517, 2021

BEYDEMİR, ŞÜKRÜ Et Al. "Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies." DRUG AND CHEMICAL TOXICOLOGY , vol.44, no.5, pp.508-517, 2021

BEYDEMİR, Ş. TÜRKEŞ, C. And Yalcin, A. (2021) . "Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies." DRUG AND CHEMICAL TOXICOLOGY , vol.44, no.5, pp.508-517.

@article{article, author={ŞÜKRÜ BEYDEMİR Et Al. }, title={Gadolinium-based contrast agents: in vitro paraoxonase 1 inhibition, in silico studies}, journal={DRUG AND CHEMICAL TOXICOLOGY}, year=2021, pages={508-517} }